InvestorsObserver
×
News Home

CorMedix Inc (CRMD) has risen 7.34% in a Week, Should You Buy?

Friday, March 15, 2024 09:45 AM | InvestorsObserver Analysts

Mentioned in this article

CorMedix Inc (CRMD) has risen 7.34% in a Week, Should You Buy?

CorMedix Inc (CRMD) is around the top of the Biotechnology industry according to InvestorsObserver. CRMD received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. CorMedix Inc also achieved a score of 79 in the Biotechnology industry, putting it above 79 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.

Overall Score - 65
CRMD has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CRMD!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With CorMedix Inc Stock Today?

CorMedix Inc (CRMD) stock is trading at $3.95 as of 9:45 AM on Friday, Mar 15, a loss of -$0.23, or -5.5% from the previous closing price of $4.18. The stock has traded between $3.95 and $4.21 so far today. Volume today is low. So far 147,753 shares have traded compared to average volume of 456,914 shares. Click Here to get the full Stock Report for CorMedix Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App